Advocacy intelligence hub — real-time data for patient organizations
Revolution Medicines, Inc. — PHASE1
Children's Oncology Group
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Multilocular cystic renal neoplasm of low malignant potential news →
View all Multilocular cystic renal neoplasm of low malignant potential specialists →